Pull to refresh
Logo
Daily Brief
Following Why Ranks Sign Up
NA

Neeraj Agarwal

Global lead investigator, TALAPRO-3

Appears in 1 story

Notable Quotes

The benefit held up in both the BRCA and the broader non-BRCA groups. (ASCO 2026 presentation)

Stories

Talazoparib trial moves a targeted prostate cancer drug to an earlier stage

New Capabilities

Presented the final results at ASCO 2026

About one in four men with advanced prostate cancer carry inherited flaws in the genes that repair damaged DNA. A large trial now shows that giving those men a targeted pill alongside standard hormone therapy delays the cancer's spread by a wide margin.

Updated Yesterday